Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial.

Meininger V, Drory VE, Leigh NP, Ludolph A, Robberecht W, Silani V

Amyotroph Lateral Scler. 2009 Oct-Dec; 10(5-6):378-83. PMID: 19922128. Abstract